Peripheral Neuropathy

Managing Treatment-related Peripheral Neuropathy in Patients with Multiple Myeloma

Managing Treatment-related Peripheral Neuropathy in Patients with Multiple Myeloma

[Blood and Lymphatic Cancer: Targets and Therapy] This research reviews clinical symptoms, diagnosis, and risk factors of peripheral neuropathy, particularly dealing with the incidence, mechanisms, and management of TiPN and BiPN.

Tango Dancing Improves Balance and Fall Risk in Cancer Patients With Peripheral Neuropathy

Tango Dancing Improves Balance and Fall Risk in Cancer Patients With Peripheral Neuropathy

By

Balanced is improved and fall risk is reduced among cancer patients with peripheral neuropathy who participated in Argentine tango dancing as a form of therapy.

Genetic Biomarker Predictive of Peripheral Neuropathy in Patients Receiving Docetaxel for Prostate Cancer

By

Docetaxel-induced neuropathy may be predicted by single nucleotide polymorphisms in VAC14.

Neurofeedback Training Enables Cancer Survivors to Control Chemotherapy-Induced Peripheral Neuropathy

By

Chronic pain was decreased and quality of life was increased through neurofeedback.

Rare gene variants associated with side effects from paclitaxel

By

Researchers have identified the first genetic marker associated with severe neurologic toxicity from paclitaxel.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs